DeepMed Research

TEHRAN UNIVERSITY OF MEDICAL SCIENCES

🇮🇷Iran

Country: 🇮🇷Iran

Ownership: Private

Established: 1934-01-01

Employees: 1K

Market Cap: -

Website: http://www.tums.ac.ir

Clinical Trials

Metformin Effects on Oxidative Stress Parameters in Newly Diagnosed Type 2 Diabetes Patients

Not Applicable

Completed

Conditions: Type 2 Diabetes Mellitus

Interventions: Drug: Metformin

First Posted Date: 2012-01-30

Last Posted Date: 2012-01-31

Lead Sponsor: Tehran University of Medical Sciences

Target Recruit Count: 108

Registration Number: NCT01521624

Locations: 🇮🇷
Tehran University of Medical Sciences, Tehran, Iran, Islamic Republic of

The Effect of Adding Sufentanyl to Bupivacaine in Transversus Abdominis Plane Block to Reduce the Narcotic Dosage and Pain After Cesarean Delivery

Phase 4

Completed

Conditions: Pain

Interventions: Drug: Sufentanyl

First Posted Date: 2012-01-24

Last Posted Date: 2013-03-27

Lead Sponsor: Tehran University of Medical Sciences

Target Recruit Count: 50

Registration Number: NCT01516268

Locations: 🇮🇷
Shariati hospital, TUMS, Tehran, Iran, Islamic Republic of

A Parent-only Group Cognitive Behavioral Intervention for Children With Anxiety Disorders: a Control Group Study

Not Applicable

Completed

Conditions: Anxiety Disorders

Interventions: Other: Group cognitive behavioral intervention

First Posted Date: 2012-01-20

Last Posted Date: 2016-04-26

Lead Sponsor: Tehran University of Medical Sciences

Target Recruit Count: 40

Registration Number: NCT01513915

Locations: 🇮🇷
Rouzbeh Hospital, Tehran, Iran, Islamic Republic of

The Impact of Omega-3 Supplementation on Gene Expression in Type 2 Diabetics

Phase 4

Conditions: Type 2 Diabetes

Interventions: Dietary Supplement: omega-3
Dietary Supplement: placebo

First Posted Date: 2011-11-23

Last Posted Date: 2012-12-03

Lead Sponsor: Tehran University of Medical Sciences

Target Recruit Count: 20

Registration Number: NCT01478776

Locations: 🇮🇷
Tehran University of Medical Sciences, Tehran, Iran, Islamic Republic of

Sequential Left Prefrontal Repetitive Transcranial Magnetic Stimulation, With High Frequency, for Treatment-Resistant Depression

Not Applicable

Conditions: Treatment-Resistant Depression Disease

Interventions: Other: Sham rTMS
Other: Repetitive Transcranial Magnetic Stimulation

First Posted Date: 2011-11-10

Last Posted Date: 2011-11-22

Lead Sponsor: Tehran University of Medical Sciences

Target Recruit Count: 60

Registration Number: NCT01469325

Locations: 🇮🇷
Iranian National Center for Addiction Studies, Tehran, Iran, Islamic Republic of

Two Schedules of Hepatitis B Vaccination in Predialysis Chronic Renal Failure Patients

Not Applicable

Completed

Conditions: Renal Failure

Interventions: Biological: four doses of Euvax B vaccine
Biological: 20 μg (1 ml) three doses of Euvax B vaccine

First Posted Date: 2011-11-09

Last Posted Date: 2011-11-09

Lead Sponsor: Tehran University of Medical Sciences

Target Recruit Count: 51

Registration Number: NCT01468051

Efficacy of Intravenous (IV) Paracetamol for Treatment of Acute Pain

Phase 4

Completed

Conditions: Acute Pain

Interventions: Drug: Paracetamol

First Posted Date: 2011-11-06

Last Posted Date: 2012-12-10

Lead Sponsor: Tehran University of Medical Sciences

Target Recruit Count: 60

Registration Number: NCT01465984

Locations: 🇮🇷
TUMS, Tehran, Iran, Islamic Republic of

The Effect of Heparin on Inhalation Injury

Phase 3

Withdrawn

Conditions: Heparin

Interventions: Drug: standard care
Drug: Heparin

First Posted Date: 2011-10-19

Last Posted Date: 2012-12-17

Lead Sponsor: Tehran University of Medical Sciences

Registration Number: NCT01454869

Locations: 🇮🇷
Shahid Mothary Burn Hospital, Tehran, Iran, Islamic Republic of

Oral Selenium Therapy for the Prevention of Mucositis

Phase 1

Conditions: Mucositis
Hematopoietic Stem Cell Transplantation

Interventions: Drug: Oral selenium
Drug: Oral placebo

First Posted Date: 2011-09-13

Last Posted Date: 2012-06-04

Lead Sponsor: Tehran University of Medical Sciences

Target Recruit Count: 76

Registration Number: NCT01432873

Locations: 🇮🇷
Hematology-Oncology & SCT Research Center, Tehran, Iran, Islamic Republic of

Impact of Vitamin A on Multiple Sclerosis (MS)

Phase 4

Conditions: Relapsing Remitting Multiple Sclerosis

Interventions: Dietary Supplement: vitamin A

First Posted Date: 2011-08-16

Last Posted Date: 2011-08-16

Lead Sponsor: Tehran University of Medical Sciences

Target Recruit Count: 100

Registration Number: NCT01417273

Locations: 🇮🇷
Tehran University of Medical Sciences,, Tehran, Iran, Islamic Republic of

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy